Earnings History Data for Iterum Therapeutics plc (ITRM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Iterum Therapeutics plc

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-03-2024	PM		ITRM	Iterum Therapeutics plc	20.96	-0.94	-1.02	-0.41	Iterum Therapeutics Non-GAAP EPS of -$0.81 [3/28/2024 7:01 AM]	1.54	-0.05 (-3.14%)	1.69	0.10 (6.29%)	0.62 - 2.50	204,811	130,000	19,455
Iterum Therapeutics Non-GAAP EPS of -$0.81 [3/28/2024 7:01 AM]
14-11-2023	PM		ITRM	Iterum Therapeutics plc	10.30	-0.30	-0.91	-0.43	Iterum Therapeutics GAAP EPS of -$0.30 [11/14/2023 7:01 AM]	0.7450	-0.02 (-3.23%)	0.73	-0.04 (-5.18%)	0.60 - 1.54	40,187	30,000	3,237
Iterum Therapeutics Q3 2023 Earnings Preview [11/13/2023 10:25 AM] Iterum Therapeutics GAAP EPS of -$0.30 [11/14/2023 7:01 AM]
11-08-2023	PM		ITRM	Iterum Therapeutics plc	13.20	-0.95	-0.80	-0.45	Iterum Therapeutics GAAP EPS of -$0.95 misses by $0.15 [8/11/2023 7:08 AM]	1.09	0.08 (7.92%)	1.11	0.10 (9.90%)	0.60 - 4.35	77,417	70,000	6,023
Iterum Therapeutics GAAP EPS of -$0.95 misses by $0.15 [8/11/2023 7:08 AM]
16-03-2023	PM	7:00 AM ET (Mar 16)	ITRM	Iterum Therapeutics plc	14.19	-0.41	-1.22	-0.45	Iterum Therapeutics Non-GAAP EPS of -$0.52 beats by $0.63 [3/16/2023 7:03 AM]	1.15	0.15 (15.00%)	0.0	0.0 (0.00%)	0.60 - 7.05	488,273	50,000	0
Iterum Therapeutics Q4 2022 Earnings Preview [3/15/2023 1:27 PM] Iterum Therapeutics Non-GAAP EPS of -$0.52 beats by $0.63 [3/16/2023 7:03 AM]
10-11-2022	PM	7:00 AM ET (Nov 10)	ITRM	Iterum Therapeutics plc	18.96	-0.43	-0.92	-0.45	Iterum Therapeutics Non-GAAP EPS of -$0.43 beats by $0.49 [11/10/2022 7:01 AM]	1.41	-0.02 (-1.05%)	1.39	-0.04 (-2.46%)	1.39 - 9.15	64,465	50,000	691
Iterum Therapeutics Q3 2022 Earnings Preview [11/9/2022 1:30 PM] Iterum Therapeutics Non-GAAP EPS of -$0.43 beats by $0.49 [11/10/2022 7:01 AM]
28-03-2022	PM	7:00 AM ET (Mar 28)	ITRM	Iterum Therapeutics plc	80.22	-0.03	0.00	-0.11	Iterum Therapeutics GAAP EPS of -$0.02 beats by $0.02 [3/28/2022 7:02 AM]	0.3839	-0.06 (-14.27%)	0.39	0.0 (0.81%)	0.28 - 2.52	4,347,319	1,320,000	223
Iterum Therapeutics GAAP EPS of -$0.02 beats by $0.02 [3/28/2022 7:02 AM] Iterum Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-28-22 07:00AM] Iterum Expects To Start Additional Sulopenem Trial In Urinary Tract Infections In 2H22 [Mar-28-22 10:19AM]
12-11-2021	PM	7:00 AM ET (Nov 12)	ITRM	Iterum Therapeutics plc	103.87	-0.03	-0.03	-0.34	Iterum Therapeutics EPS beats by $0.01 [11/12/2021 7:07 AM]	0.5680	-0.04 (-6.73%)	0.59	-0.02 (-3.32%)	0.50 - 3.00	7,437,350	5,390,000	1,081,610
Iterum Therapeutics EPS beats by $0.01 [11/12/2021 7:07 AM] Iterum Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-12-21 07:00AM]
13-08-2021	PM	7:00 AM ET (Aug 13)	ITRM	Iterum Therapeutics plc	125.04	-0.04	-0.04	-0.80	Iterum Therapeutics EPS beats by $0.02 [8/13/2021 7:03 AM]	0.6981	-0.03 (-4.34%)	0.73	0.0 (0.03%)	0.45 - 3.00	3,660,513	4,720,000	184,728
Iterum Therapeutics Q2 2021 Earnings Preview [8/12/2021 1:24 PM] Iterum Therapeutics EPS beats by $0.02 [8/13/2021 7:03 AM] LAWSUITS FILED AGAINST JRVR, HMPT and ITRM - Jakubowitz Law Pursues Shareholders Claims [Aug-12-21 05:05PM] ITRM NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit [Aug-12-21 04:04PM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DKNG, BLCT and ITRM [Aug-12-21 12:45PM] SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-12-21 12:05PM] ONGOING INVESTIGATION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Iterum Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Aug-12-21 11:53AM] CLASS ACTION UPDATE for CCIV, ATVI and ITRM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Aug-12-21 10:30AM] ITRM Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Iterum Therapeutics plc Shareholders of Class Action and Encourages Investors to Contact the Firm [Aug-12-21 10:00AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCIV, AHCO and ITRM [Aug-12-21 05:40AM] Iterum Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-13-21 07:00AM] ITRM CLASS ACTION DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc [Aug-13-21 10:00AM] The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DKNG, QFIN and ITRM [Aug-13-21 10:45AM] ITRM Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Iterum Therapeutics plc Shareholders of Class Action and Encourages Investors to Contact the Firm [Aug-13-21 11:00AM] The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HMPT, CRMD and ITRM [Aug-13-21 11:45AM] SHAREHOLDER ALERT: Robbins LLP Announces that Iterum Therapeutics PLC (ITRM) is Being Sued for Misleading Shareholders [Aug-13-21 12:30PM] Lawsuits Filed Against CCIV, AHCO and ITRM - Jakubowitz Law Pursues Shareholders Claims [Aug-13-21 01:05PM] ITRM Breaking Alert: Nationally Ranked Rosen Law Firm Encourages Iterum Therapeutics plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ITRM [Aug-13-21 03:31PM] SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Iterum Therapeutics Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ITRM [Aug-13-21 04:57PM]
14-05-2021	PM	7:00 AM ET (May 14)	ITRM	Iterum Therapeutics plc	184.51	-0.05	-0.04	-0.90	Iterum Therapeutics EPS misses by $0.75 [5/14/2021 7:02 AM]	1.03	0.07 (6.70%)	1.00	0.03 (3.09%)	0.45 - 6.02	6,968,498	5,800,000	333,322
Iterum Therapeutics EPS misses by $0.75 [5/14/2021 7:02 AM] Iterum Therapeutics up 7% despite Q1 EPS miss [5/14/2021 10:15 AM] Iterum Therapeutics Reports First Quarter 2021 Financial Results [May-14-21 07:00AM]
12-03-2021	PM	6:45 AM ET (Mar 12)	ITRM	Iterum Therapeutics plc	210.47	-0.11	-0.14	-1.59	Iterum Therapeutics EPS beats by $0.06 [3/12/2021 7:03 AM]	1.58	-0.02 (-1.26%)	1.68	0.08 (5.00%)	0.45 - 6.02	25,052,047	17,393,070	6,206,816
Iterum Therapeutics EPS beats by $0.06 [3/12/2021 7:03 AM] Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-12-21 07:00AM]
16-11-2020	PM		ITRM	Iterum Therapeutics plc	19.11	-0.34	-0.43	-2.15	Iterum Therapeutics EPS beats by $0.45 [11/16/2020 6:48 AM]	0.5001	-0.02 (-3.83%)	0.52	0.0 (0.00%)	0.45 - 7.19	1,379,368	1,836,779	21,215